BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36930561)

  • 1. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
    Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
    Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ro52/TRIM21 - From host defense to autoimmunity.
    Holwek E; Opinc-Rosiak A; Sarnik J; Makowska J
    Cell Immunol; 2023; 393-394():104776. PubMed ID: 37857191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
    Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
    Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
    Chan EKL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
    Lee AYS; Lin MW; Reed JH
    Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
    Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
    Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.
    Hsu CH; Yu YL
    Cancer Cell Int; 2023 Nov; 23(1):289. PubMed ID: 37993883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
    Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
    Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
    Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
    Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
    ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.
    Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjöstrand M; Eloranta ML; Ní Gabhann J; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
    J Exp Med; 2009 Aug; 206(8):1661-71. PubMed ID: 19635858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
    Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
    Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
    Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
    J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
    Liu K; Liao Y; Li P; Shi J
    J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
    Lee AYS
    Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
    Murng SHK; Thomas M
    J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus.
    Gomez-Bañuelos E; Wahadat MJ; Li J; Paz M; Antiochos B; Celia AI; Andrade V; Ferris DP; Goldman DW; Darrah E; Petri M; Andrade F
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.
    Kunishita Y; Yoshimi R; Kamiyama R; Kishimoto D; Komiya T; Sakurai N; Sugiyama Y; Takase-Minegishi K; Kirino Y; Nagaoka S; Nakajima H
    Lupus; 2021 Nov; 30(13):2054-2065. PubMed ID: 34565210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study.
    Vázquez-Del Mercado M; Martínez-García EA; Daneri-Navarro A; Gómez-Bañuelos E; Martín-Márquez BT; Pizano-Martínez O; Wilson-Manríquez EA; Corona-Sánchez EG; Chavarria-Avila E; Sandoval-García F; Satoh M
    Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):328-333. PubMed ID: 33876712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.